SGLT

信号通路图

研究领域

抑制剂选择性比较

特异性亚型抑制剂

SGLT产品

所有产品 SGLT抑制剂(14)

目录号	产品描述	文献引用	实验数据
S1548	Dapagliflozin Dapagliflozin (BMS-512148) 是一种有效的，选择性的hSGLT2抑制剂，EC50为1.1 nM，比作用于hSGLT1选择性高1200倍。Phase 4。	Elife, 2020, 9e56749 Redox Biol, 2020, 2;32:101527 Diabetes Obes Metab, 2020, 20	Effects of once-daily administration of DAPA, DAPA switched to (DAla2)GIP or saline vehicle on (AeD) DEXA images, (E) body fat, (F) lean mass, (G) bone mineral content and (H) bone mineral density in high fat fed mice. Mice received saline vehicle (0.9% wt/vol; po), DAPA (1 mg/kg; po) once-daily over 28 days, or DAPA (1 mg/kg; po) once-daily over 14 days followed by (DAla2)GIP (25 nmol/kg; ip) once-daily for 14 days. Lean control mice received saline vehicle once-daily. White bars=lean controls; grey bars=HF controls; black bars=DAPA; and hatched bars=DAPA / GIP. Values are mean ± SEM for groups of 6-8 mice. p < 0.05 and *p < 0.01 compared to HF controls.
S2760	Canagliflozin Canagliflozin (TA 7284, JNJ 28431754)是一种高效的，选择性SGLT2抑制剂，作用于hSGLT2，无细胞试验中IC50为2.2 nM，比作用于hSGLT1选择性高413倍。	Redox Biol, 2020, 2;32:101527 Diabetes Obes Metab, 2020, 20 Life Sci, 2020, 247:117414	Canagliflozin dose-dependently increases pAMPK and pACC in PC3 cells after 30 min
S8022	Empagliflozin (BI 10773) Empagliflozin (BI 10773)是一种有效的，选择性SGLT-2抑制剂，IC50为3.1 nM，比作用于SGLT-1， 4， 5和6选择性高300倍以上。Phase 3。	Redox Biol, 2020, 2;32:101527 Cell Signal, 2020, 77:109825 J Chromatogr B Analyt Technol Biomed Life Sci, 2020, 1141:122020	Effects of empagliflozin on AMPK/ACC phosphorylation
S5901	Canagliflozin hemihydrate Canagliflozin hemihydrate是canagliflozin的半水化合物形式。Canagliflozin是SGLT2的抑制剂，对hSGLT2的IC50值为2.2 nM，对hSGLT2的选择性是对hSGLT1的413倍。
S8103	Sotagliflozin (LX4211) Sotagliflozin (LX4211)是一种口服的双重SGLT1/SGLT2抑制剂，IC50分别为 36 nM 和 1.8 nM。Phase 3。	J Cell Mol Med, 2018, 22(11):5367-5377 Vascul Pharmacol, 2018, 109:56-71
S0994^New	Ipragliflozin L-Proline Ipragliflozin L-Proline 是一种口服活性的 SGLT2 的选择性抑制剂，对人SGLT2、大鼠SGLT2和小鼠SGLT2的IC50分别为7.38 nM、6.73 nM和5.64 nM。
S8938^New	KGA-2727 KGA-2727是一种有效、选择性的、高亲和力的 sodium glucose cotransporter 1 (SGLT1) 抑制剂，对human SGLT1和rat SGLT1的Ki值分别为97.4 nM和43.5 nM。KGA-2727的选择性比(Ki for SGLT2/Ki for SGLT1)为140 (human)和390 (rat)。 KGA-2727在啮齿动物模型中显示出抗糖尿病功效。
S8939^New	Mizagliflozin Mizagliflozin是一种新型、有效、选择性的 sodium glucose co-transporter 1 (SGLT1) 抑制剂，对human SGLT1的Ki值为27 nM。Mizagliflozin的选择性比(Ki value for human SGLT2/Ki value for human SGLT1)为303。Mizagliflozin还有改善慢性便秘的潜在应用。
S8558	Tofogliflozin(CSG 452) Tofogliflozin (CSG 452) 是一种新型的sodium-glucose co-transporter 2(SGLT2)抑制剂，对hSGLT2和hSGLT1的IC50值分别为2.9 nM和8444 nM。
S5566	Dapagliflozin propanediol monohydrate Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors.	Am J Physiol Renal Physiol, 2019, 316(5):F1078-F1089
S8637	Ipragliflozin (ASP1941) Ipragliflozin (ASP1941)是一种高度选择性的sodium-glucose cotransporter 2 (SGLT2)抑制剂，对hSGLT2的IC50值为7.4 nM，对SGLT2的选择性是对SGLT1的选择性的254倍。
S2342	Phloretin Phloretin (Dihydronaringenin) 是一种二氢查尔酮，含有多元酚。	Oxid Med Cell Longev, 2019, 2019:2084805 J Transl Med, 2017, 15(1):158 J Agric Food Chem, 2017, 65(31):6625-6637	Specificity of FDG uptake in BJAB, OCI-LY3 and SU-DHL-6 cells. Cells were incubated without inhibitors or with 2 mM 2-DG, 5 μM cytochalasin B or 10 μM phloretin for 24 h or with 50 μM CoCl2 for 30 min and 100 kBq of FDG for 30 min. Cell-bound radioactivity was normalized to protein concentration determined from a parallel sample and expressed as % of untreated control, mean ± standard deviation from fourfold determinations; Asterisks indicates significant decrease or increase (p < 0.05, Student’s t test)
S2343	Phlorizin Phlorizin (Phloridzin) 是有毒的2'-葡萄糖苷根皮素，属于二氢查尔酮，是一种黄酮类化合物。	Int J Biol Sci, 2019, 15(11):2497-2508 Am J Physiol Renal Physiol, 2019, 316(5):F1078-F1089 Nat Prod Bioprospect, 2019, 9(1):13-21	PQ increases glucose transport and the translocation of glucose transporters. Cells were treated with PQ for 48 h. The survival of cells treated with PQ in the presence or absence of phlorizin (e) was determined. Bar graph represents percents of viable cells (cell survival).
S5413	Ertugliflozin Ertugliflozin (MK-8835, PF-04971729) is a potent and selective sodium-dependent glucose cotransporter 2 inhibitor with IC50 values of 0.877 nM for h-SGLT2 and 1000-fold higher for h-SGLT1.

目录号	产品描述	文献引用	实验数据
S1548	Dapagliflozin Dapagliflozin (BMS-512148) 是一种有效的，选择性的hSGLT2抑制剂，EC50为1.1 nM，比作用于hSGLT1选择性高1200倍。Phase 4。	Elife,2020, 9e56749 Redox Biol,2020, 2;32:101527 Diabetes Obes Metab,2020, 20	Effects of once-daily administration of DAPA, DAPA switched to (DAla2)GIP or saline vehicle on (AeD) DEXA images, (E) body fat, (F) lean mass, (G) bone mineral content and (H) bone mineral density in high fat fed mice. Mice received saline vehicle (0.9% wt/vol; po), DAPA (1 mg/kg; po) once-daily over 28 days, or DAPA (1 mg/kg; po) once-daily over 14 days followed by (DAla2)GIP (25 nmol/kg; ip) once-daily for 14 days. Lean control mice received saline vehicle once-daily. White bars=lean controls; grey bars=HF controls; black bars=DAPA; and hatched bars=DAPA / GIP. Values are mean ± SEM for groups of 6-8 mice. p < 0.05 and *p < 0.01 compared to HF controls.
S2760	Canagliflozin Canagliflozin (TA 7284, JNJ 28431754)是一种高效的，选择性SGLT2抑制剂，作用于hSGLT2，无细胞试验中IC50为2.2 nM，比作用于hSGLT1选择性高413倍。	Redox Biol,2020, 2;32:101527 Diabetes Obes Metab,2020, 20 Life Sci,2020, 247:117414	Canagliflozin dose-dependently increases pAMPK and pACC in PC3 cells after 30 min
S8022	Empagliflozin (BI 10773) Empagliflozin (BI 10773)是一种有效的，选择性SGLT-2抑制剂，IC50为3.1 nM，比作用于SGLT-1， 4， 5和6选择性高300倍以上。Phase 3。	Redox Biol,2020, 2;32:101527 Cell Signal,2020, 77:109825 J Chromatogr B Analyt Technol Biomed Life Sci,2020, 1141:122020	Effects of empagliflozin on AMPK/ACC phosphorylation
S5901	Canagliflozin hemihydrate Canagliflozin hemihydrate是canagliflozin的半水化合物形式。Canagliflozin是SGLT2的抑制剂，对hSGLT2的IC50值为2.2 nM，对hSGLT2的选择性是对hSGLT1的413倍。
S8103	Sotagliflozin (LX4211) Sotagliflozin (LX4211)是一种口服的双重SGLT1/SGLT2抑制剂，IC50分别为 36 nM 和 1.8 nM。Phase 3。	J Cell Mol Med,2018, 22(11):5367-5377 Vascul Pharmacol,2018, 109:56-71
S0994^New	Ipragliflozin L-Proline Ipragliflozin L-Proline 是一种口服活性的 SGLT2 的选择性抑制剂，对人SGLT2、大鼠SGLT2和小鼠SGLT2的IC50分别为7.38 nM、6.73 nM和5.64 nM。
S8938^New	KGA-2727 KGA-2727是一种有效、选择性的、高亲和力的 sodium glucose cotransporter 1 (SGLT1) 抑制剂，对human SGLT1和rat SGLT1的Ki值分别为97.4 nM和43.5 nM。KGA-2727的选择性比(Ki for SGLT2/Ki for SGLT1)为140 (human)和390 (rat)。 KGA-2727在啮齿动物模型中显示出抗糖尿病功效。
S8939^New	Mizagliflozin Mizagliflozin是一种新型、有效、选择性的 sodium glucose co-transporter 1 (SGLT1) 抑制剂，对human SGLT1的Ki值为27 nM。Mizagliflozin的选择性比(Ki value for human SGLT2/Ki value for human SGLT1)为303。Mizagliflozin还有改善慢性便秘的潜在应用。
S8558	Tofogliflozin(CSG 452) Tofogliflozin (CSG 452) 是一种新型的sodium-glucose co-transporter 2(SGLT2)抑制剂，对hSGLT2和hSGLT1的IC50值分别为2.9 nM和8444 nM。
S5566	Dapagliflozin propanediol monohydrate Dapagliflozin propanediol belongs to the class of orally administered antidiabetic agents designated as sodiumglucose cotransporter 2 (SGLT2) inhibitors.	Am J Physiol Renal Physiol,2019, 316(5):F1078-F1089
S8637	Ipragliflozin (ASP1941) Ipragliflozin (ASP1941)是一种高度选择性的sodium-glucose cotransporter 2 (SGLT2)抑制剂，对hSGLT2的IC50值为7.4 nM，对SGLT2的选择性是对SGLT1的选择性的254倍。
S2342	Phloretin Phloretin (Dihydronaringenin) 是一种二氢查尔酮，含有多元酚。	Oxid Med Cell Longev,2019, 2019:2084805 J Transl Med,2017, 15(1):158 J Agric Food Chem,2017, 65(31):6625-6637	Specificity of FDG uptake in BJAB, OCI-LY3 and SU-DHL-6 cells. Cells were incubated without inhibitors or with 2 mM 2-DG, 5 μM cytochalasin B or 10 μM phloretin for 24 h or with 50 μM CoCl2 for 30 min and 100 kBq of FDG for 30 min. Cell-bound radioactivity was normalized to protein concentration determined from a parallel sample and expressed as % of untreated control, mean ± standard deviation from fourfold determinations; Asterisks indicates significant decrease or increase (p < 0.05, Student’s t test)
S2343	Phlorizin Phlorizin (Phloridzin) 是有毒的2'-葡萄糖苷根皮素，属于二氢查尔酮，是一种黄酮类化合物。	Int J Biol Sci,2019, 15(11):2497-2508 Am J Physiol Renal Physiol,2019, 316(5):F1078-F1089 Nat Prod Bioprospect,2019, 9(1):13-21	PQ increases glucose transport and the translocation of glucose transporters. Cells were treated with PQ for 48 h. The survival of cells treated with PQ in the presence or absence of phlorizin (e) was determined. Bar graph represents percents of viable cells (cell survival).
S5413	Ertugliflozin Ertugliflozin (MK-8835, PF-04971729) is a potent and selective sodium-dependent glucose cotransporter 2 inhibitor with IC50 values of 0.877 nM for h-SGLT2 and 1000-fold higher for h-SGLT1.